Iterum Therapeutics plc (ITRMF) Convertible Debt (2023)

Iterum Therapeutics' Convertible Debt history runs 1 years deep, the most recent figure standing at $11.5 million for Q4 2023.

• In Q4 2023, Convertible Debt changed N/A year-over-year to $11.5 million; the TTM figure through Dec 2023 stood at $11.5 million (changed N/A YoY), while the FY2023 annual figure was $11.5 million, changed N/A from the prior year.
• Convertible Debt for Q4 2023 stood at $11.5 million.
• The five-year high for Convertible Debt was $11.5 million in Q4 2023, with the low at $11.5 million in Q4 2023.